Primary Record
Cilastatin sodium
- In stock
- 9,577 g
- Purity
- 98.1 %
- CAS
- 81129-83-1
Compound Identifiers & Properties
- CAS
- 81129-83-1
- PubChem CID
- 23663403
- SMILES
- CC1(C[C@@H]1C(=O)N/C(=C\CCCCSC[C@@H](C(=O)O)N)/C(=O)[O-])C.[Na+]
- Canonical SMILES
- CC1(C)C[C@@H]1C(=O)N/C(=C\CCCCSC[C@H](N)C(=O)O)C(=O)[O-].[Na+]
Names & Synonyms
- Cilastatin sodium
- Cilastatino
- Cilastatin sodium salt
- 81129-83-1
- Cilastatin natrium
- CILASTATIN Na
- Sodium, Cilastatin
- Cilastatin sodium CRS
- RefChem:577133
- Cilastatin Monosodium Salt
- DTXSID2046915
- MLS001401364
- Monosodium Salt, Cilastatin
- Salt, Cilastatin Monosodium
- DTXCID0026915
- C16H26N2O5S.Na
- UNII-5428WXZ74M
- MFCD08459332
- Cilastatin sodium [USAN:JAN]
- CHEMBL1201057
- Cilastatin sodium (JP17/USP)
- SCHEMBL29889075
- CHEBI:59511
- MK-791
- QXPBTTUOVWMPJN-QBNHLFMHSA-M
- 4-bromo-4,4-difluoro-1-butanol
- 5428WXZ74M
- HMS2051L07
- HMS2233J15
- EX-A4989
- C16-H26-N2-O5-S.Na
- Cilastatin sodium [USAN:USP:JAN]
- EINECS 279-694-4
- Tox21_112591
- Tox21_112804
- MK 791
- AKOS015962007
- AC-3375
- CCG-100932
- CID6917946
- FC61442
- MK 0791
- NC00182
- Cilastatin for system suitability 1 CRS
- Cilastatin for system suitability 2 CRS
- NCGC00167838-01
- NCGC00181346-01
- AN-13050
- BC164306
- BC209125
- CPD000469147
- SAM001246552
- SMR000469147
- SY234529
- Cilastatin sodium 100 microg/mL in Water
- Cilastatin sodium salt - Bio-X trade mark
- CAS-81129-83-1
- RECARBRIO COMPONENT CILASTATIN SODIUM
- B7156
- A10886
- D02194
- L 642957
- A840047
- L-642957
- Cilastatin for System Suitability 1 CRS (Y0001651)
- Cilastatin for System Suitability 2 CRS (Y0001652)
- B0084-077802
- Sodium (Z)-7-(((R)-2-amino-2-carboxyethyl)thio)-2-((S)-2,2-dimethylcyclopropane-1-carboxamido)hept-2-enoate
- sodium;(Z)-7-[(2R)-2-amino-2-carboxyethyl]sulfanyl-2-[[(1S)-2,2-dimethylcyclopropanecarbonyl]amino]hept-2-enoate
- Sodium;(Z)-7-[(2S)-2-amino-2-carboxyethyl]sulfanyl-2-[[(1S)-2,2-dimethylcyclopropanecarbonyl]amino]hept-2-enoate
- Sodium (Z)-7-(((R)-2-amino-2-carboxyethyl)thio)-2-((S)-2,2-dimethylcyclopropanecarboxamido)-2-heptenoate
- 2-heptenoicacid,7-((2-amino-2-carboxyethyl)thio)-2-(((2,2-dimethylcyclopropyl
- [R-[R*,S*-(Z)]]-7-[(2-Amino-2-carboxyethyl)thio]-2- [[(2,2-dimethylcyclopropyl)carbonyl]amino]-2- heptenoic acid monosodium salt
- 2-Heptenoic acid, 7-((2-amino-2-carboxyethyl)thio)-2-(((2,2-dimethylcyclopropyl)carbonyl)amino)-, monosodium salt, (R-(R*,S*-(Z)))-
- Cilastatin sodium; Sodium (Z)-7-[[(R)-2-amino-2-carboxyethyl]sulfanyl]-2-[[[(1S)-2,2-dimethylcyclopropyl]carbonyl]amino]hept-2-enoate; 2-Heptenoic acid, 7-[[(2R)-2-amino-2-carboxyethyl]thio]-2-[[[(1S)-2,2-dimethylcyclopropyl]carbonyl]amino]-, sodium salt (1:1), (2Z)-; 2-Heptenoic acid, 7-[(2-amino-2-carboxyethyl)thio]-2-[[(2,2-dimethylcyclopropyl)carbonyl]amino]-, monosodium salt, [R-[R*,S*-(Z)]]-; 2-Heptenoic acid, 7-[[(2R)-2-amino-2-carboxyethyl]thio]-2-[[[(1S)-2,2-dimethylcyclopropyl]carbonyl]amino]-, monosodium salt, (2Z)- (9CI); Cilastatin sodium salt; L 642957; MK 791
- CS
- Monosodium (2Z)-7-(((2R)-2-amino-2-carboxyethyl)sulfanyl)-2-((((1S)-2,2-dimethylcyclopropyl)carbonyl)amino)hept-2-enoate
- Sodium (2Z)-7-{[(2R)-2-amino-2-carboxyethyl]sulfanyl}-2-[(1S)-2,2-dimethylcyclopropane-1-carboxamido]hept-2-enoate
- sodium (Z)-7-[(2R)-2-amino-2-carboxy-ethyl]sulfanyl-2-[[(1S)-2,2-dimethylcyclopropanecarbonyl]amino]hept-2-enoate
- Sodium (Z)-7-[[(R)-2-amino-2-carboxyethyl]thio]-2-[(S)-2,2-dimethylcyclopropanecarboxamido]-2-heptenoate
- Sodium hydrogen [R-[R*,S*-(Z)]]-7-[(2-amino-2-carboxylatoethyl)thio]-2-[[(2,2-dimethylcyclopropyl)carbonyl]amino]hept-2-enoate
- Sodium(Z)-7-(((R)-2-amino-2-carboxyethyl)thio)-2-((S)-2,2-dimethylcyclopropane-1-carboxamido)hept-2-enoate